Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Constipation
ADR ID BADD_A01059
ADR Hierarchy
07      Gastrointestinal disorders
07.02      Gastrointestinal motility and defaecation conditions
07.02.02      Gastrointestinal atonic and hypomotility disorders NEC
07.02.02.001      Constipation
Description A disorder characterized by irregular and infrequent or difficult evacuation of the bowels. [CTCAE] Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections. | Difficult defecation. | Symptom characterized by the passage of stool once a week or less. [MeSH]
MedDRA Code 10010774
MeSH ID D003248
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Constipation | Constipation (excl faecal impaction) | Iatrogenic constipation | Obstipation | Constipation aggravated | Constipation (excl fecal impaction) | Stools absent | Constipation chronic | Opioid induced constipation | Slow transit constipation | Chronic idiopathic constipation | Dyschezia | Colonic Inertia
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02428Loperamide0.002225%
BADD_D02431Colesevelam0.015268%
BADD_D02432Glycopyrronium0.018251%
BADD_D02434Cinacalcet0.153188%
BADD_D02436Atorvastatin--
BADD_D02437Diclofenamide--
BADD_D02438Enoxaparin--
BADD_D02440Lisdexamfetamine--
BADD_D02441Rasagiline0.014884%
BADD_D02442Magnesium oxide0.001461%
BADD_D02443Tiotropium--
BADD_D02445Solifenacin0.012739%
BADD_D02448Lorcaserin0.001987%
BADD_D02451Pimavanserin0.021672%
BADD_D02453Midostaurin0.001598%
BADD_D02454Panobinostat0.001066%
BADD_D02456Vilazodone--
BADD_D02459Dalteparin--
BADD_D02461Lanreotide--
BADD_D02462Methylnaltrexone0.003050%
BADD_D02463Pitavastatin--
BADD_D02464Fingolimod--
BADD_D02466Levomilnacipran0.000290%
BADD_D02467Naloxegol0.015859%
BADD_D02468Cannabidiol0.004226%
BADD_D02470Nintedanib0.008259%
BADD_D02476Polyethylene glycol0.002003%
BADD_D02480Alectinib0.004795%
BADD_D02483Ribociclib0.006127%
BADD_D02484Istradefylline0.012429%
The 39th Page    First    Pre   39 40    Next   Last    Total 40 Pages